In our study, LrB was found to reduce NLRP3 inflammasomes and Caspase-1 and lower the serum content of TNF-α and IL-1β, -6, and -18, suggesting that LrB could reduce chronic inflammation in PCOS-IR patients. The gene discussed is IL1B; the disease is polycystic ovary syndrome.